These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35277354)

  • 1. Using automation to manage donor engagement and fine-tune supply and demand during the first year of the COVID-19 pandemic.
    Pina T; Lewis M; Garrison C; Razatos A
    Transfus Apher Sci; 2022 Aug; 61(4):103420. PubMed ID: 35277354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demographics of first-time donors returning for donation during the pandemic: COVID-19 convalescent plasma versus standard blood product donors.
    Van Buren NL; Rajbhandary S; Reynolds V; Gorlin JB; Stramer SL; Notari EP; Conti G; Katz L; Stubbs JR; van Buskirk CM; Kuttner K; Smith DL; Ngamsuntikul SG; Pandey S; Ward DC; Ziman A; Hiskey M; Townsend M; Sachais BS
    Transfusion; 2023 Mar; 63(3):552-563. PubMed ID: 36550639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID-19 pandemic.
    Al-Riyami AZ; Burnouf T; Wood EM; Devine DV; Oreh A; Apelseth TO; Goel R; Bloch EM; van Den Berg K; Getshen M; Louw V; Ang AL; Lee CK; Rahimi-Levene N; Stramer SL; Vassallo R; Schulze TJ; Patidar GK; Pandey HC; Dubey R; Badawi M; Hindawi S; Meshi A; Matsushita T; Sorrentino E; Grubovic Rastvorceva RM; Bazin R; Vermeulen M; Nahirniak S; Tsang HC; Vrielink H; Triyono T; Addas-Carvalho M; Hećimović A; Torres OW; Mutindu SM; Bengtsson J; Dominguez D; Sayedahmed A; Hanisa Musa R; Gautam B; Herczenik E; So-Osman C;
    Vox Sang; 2022 Jun; 117(6):822-830. PubMed ID: 35262978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 convalescent plasma donor characteristics, product disposition, and comparison with standard apheresis donors.
    Lasky B; Goodhue Meyer E; Steele WR; Crowder LA; Young PP
    Transfusion; 2021 May; 61(5):1471-1478. PubMed ID: 33458811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors driving availability of COVID-19 convalescent plasma: Insights from a demand, production, and supply model.
    Russell WA; Grebe E; Custer B
    Transfusion; 2021 May; 61(5):1370-1376. PubMed ID: 33590906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid development of a de novo convalescent plasma program in response to a global pandemic: A large southeastern U.S. blood center's experience.
    Reik R; Gammon RR; Carol N; Smith J; Grable M; Forbes S; Wu Y; Reed L; Rogers M; Prichard A; Paul S; Scholl G
    J Clin Apher; 2021 Aug; 36(4):533-546. PubMed ID: 33648025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of coronavirus disease 19 convalescent plasma donors and donations in the New York metropolitan area.
    Jain S; Garg K; Tran SM; Rask IL; Tarczon M; Nandi V; Kessler DA; Strauss D; Sachais BS; Yazdanbakhsh K; Rehmani S; Luchsinger L; Shi PA
    Transfusion; 2021 Aug; 61(8):2374-2383. PubMed ID: 33904609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion of hospital-based blood collections in the face of COVID-19 associated national blood shortage.
    Gniadek TJ; Mallek J; Wright G; Saporito C; AbiMansour N; Tangazi W; Rogers G; Zahara Z; Cummings G; Kaul K; Kang J
    Transfusion; 2020 Jul; 60(7):1470-1475. PubMed ID: 32445417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening donors for COVID-19 convalescent plasma.
    Wang HE; Ostrosky-Zeichner L; Katz J; Wanger A; Bai Y; Sridhar S; Patel B
    Transfusion; 2021 Apr; 61(4):1047-1052. PubMed ID: 33368395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deterrents in recruitment of COVID-19 convalescent plasma donors: Experience from a hospital-based blood centre in India.
    Dhiman Y; Coshic P; Pandey HC; Khatiwada B; Singh J; Mehta V; Gupta S
    Transfus Med; 2021 Jun; 31(3):149-154. PubMed ID: 33749020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoting access to COVID-19 convalescent plasma in low- and middle-income countries.
    Bloch EM; Goel R; Montemayor C; Cohn C; Tobian AAR
    Transfus Apher Sci; 2021 Feb; 60(1):102957. PubMed ID: 32972861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of a pilot program for COVID-19 convalescent plasma collection in Wuhan, China.
    Li L; Yang R; Wang J; Lv Q; Ren M; Zhao L; Chen H; Xu H; Xie S; Xie J; Lin H; Li W; Fang P; Gong L; Wang L; Wu Y; Liu Z
    Transfusion; 2020 Aug; 60(8):1773-1777. PubMed ID: 32491199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in Establishing a Coronavirus Disease 2019 (COVID-19) Convalescent Plasma Donation Program in a Multicultural Environment.
    Algora M; Mehmood T; Madison DL; AlAmeri J; Abuzakouk M; Tagamtam M; Acena L; Totaan G; Grabski G; Oumeziane N; Rajani P; Taylor L; Guzman J; AbdelWareth LO
    Arch Pathol Lab Med; 2021 Dec; 145(12):1479-1484. PubMed ID: 34407176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of blood campaigns using mobile blood collection drives on blood supply management during the COVID-19 pandemic.
    Halawani AJ
    Transfus Apher Sci; 2022 Jun; 61(3):103354. PubMed ID: 35042671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparedness and activities of the anti-SARS-CoV-2 convalescent plasma bank in the Veneto region (Italy): An organizational model for future emergencies.
    De Silvestro G; Gandini G; Fiorin F; Marson P; Barbone E; Frigato A; Gessoni G; Veronesi A; Pacenti M; Castelli M; Rinaldi M; Rizzi M; Stefani F; Roveroni G
    Transfus Apher Sci; 2021 Aug; 60(4):103154. PubMed ID: 33994107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety of plasma apheresis from donors recovering from COVID-19 infection in Japan.
    Kamo-Imai A; Togano T; Sato M; Kawakami Y; Inaba K; Shimazu H; Igarashi S; Tanaka K; Terada M; Kinoshita-Iwamoto N; Saito S; Kutsuna S; Hangaishi A; Morioka S; Takahashi K; Miyata S; Ohmagari N
    Transfus Apher Sci; 2023 Jun; 62(3):103687. PubMed ID: 36964059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Provision of COVID-19 Convalescent Plasma in a Resource-Constrained State.
    Ipe TS; Le T; Quinn B; Kellar S; Clark M; Carlisle S; Rassmann A; Hennigan S; Ridenour T; Roberts A; Avery D; Ryan S; Pearson S; Kothari A; Patil N
    Transfusion; 2020 Dec; 60(12):2828-2833. PubMed ID: 32989778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supply and demand for plasma-derived medicinal products - A critical reassessment amid the COVID-19 pandemic.
    Hartmann J; Klein HG
    Transfusion; 2020 Nov; 60(11):2748-2752. PubMed ID: 32856742
    [No Abstract]   [Full Text] [Related]  

  • 19. The impact of COVID-19 on blood safety and availability in the Islamic Republic of Iran.
    Divkolaye N; Arabkhazaeli A; Hajibeigi B; Eshghi P
    East Mediterr Health J; 2022 Nov; 28(11):823-828. PubMed ID: 36515446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convalescent plasma for COVID-19: Donor demographic factors associated high neutralising antibody titres.
    Mehew J; Johnson R; Roberts D; Griffiths A; Harvala H
    Transfus Med; 2022 Aug; 32(4):327-337. PubMed ID: 35434868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.